Interestingly, transcripts for RSAD2 were found to be upregulated in SLE CD3+ CD4+ cells, as well as SLE CD19+ B cells, and SLE CD33+ myeloid cells in comparison to similar cellular subsets isolated from healthy controls (49). This evidence concerns the gene CD4 and systemic lupus erythematosus.